Patients News | pharmaphorum

News

Trial finds Lilly’s Olumiant could treat type 1 diabetes

Treatment with Eli Lilly’s JAK inhibitor Olumiant has been shown to preserve the function of insulin-producing pancreatic beta cells in patients with type 1 diabetes, pote

News

UK primary care group adopts digital heart failure pathway

A digital approach to the care of patients with heart failure, developed by Boehringer Ingelheim and ORCHA, will be rolled out in the northwest of the UK by a primary care

News

Undiagnosed dementia in UK needs drastic action, says review

A just-published report has found that more than a third (36%) of people currently living with dementia in the UK are undiagnosed, and major changes are needed to overturn

News

Could high HDL-cholesterol raise dementia risk?

A new study has added to data suggesting that HDL cholesterol (HDL-c) – sometimes called ‘good’ cholesterol, as it can help protect against heart disease – may be a risk f

News

UK Biobank releases largest-ever genome sequencing dataset

After five years of painstaking lab work, more than 350,000 hours of genome sequencing and £200 million ($253 million) in investment, UK Biobank has completed and released the full se

News

FDA launches wide probe into CAR-T therapy safety

The FDA has announced it will start an investigation into the safety of CAR-T therapies, after becoming concerned that they may be linked to the development of T-cell canc

Trial finds Lilly’s Olumiant could treat type 1 diabetes

UK primary care group adopts digital heart failure pathway

Undiagnosed dementia in UK needs drastic action, says review

Could high HDL-cholesterol raise dementia risk?

UK Biobank releases largest-ever genome sequencing dataset

FDA launches wide probe into CAR-T therapy safety

Ultragenyx to slash costs after Angelman trial failure

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks